SAN DIEGO--(BUSINESS WIRE)--Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today an expansion of the executive team with the appointment of Thomas B. Broudy, Ph.D. to Chief Scientific Officer (CSO) and Richard Scuderi, M.D., Ph.D. to Medical Director.
